160 related articles for article (PubMed ID: 12552976)
1. Predictive value of CD8highCD57+ lymphocyte subset in interferon therapy of patients with renal cell carcinoma.
Characiejus D; Pasukoniene V; Kazlauskaite N; Valuckas KP; Petraitis T; Mauricas M; Den Otter W
Anticancer Res; 2002; 22(6B):3679-83. PubMed ID: 12552976
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood CD8highCD57+ lymphocyte levels may predict outcome in melanoma patients treated with adjuvant interferon-alpha.
Characiejus D; Pasukoniene V; Jonusauskaite R; Azlauskaite N; Aleknavicius E; Mauricas M; Otter WD
Anticancer Res; 2008; 28(2B):1139-42. PubMed ID: 18505049
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of peripheral blood lymphocyte subsets in patients with renal cell carcinoma.
Arima K; Nakagawa M; Yanagawa M; Sugimura Y; Tochigi H; Kawamura J
Urol Int; 1996; 57(1):5-10. PubMed ID: 8840483
[TBL] [Abstract][Full Text] [Related]
4. Can the CD4+/CD8+ ratio predict the outcome of interferon-alpha therapy for renal cell carcinoma?
Hernberg M; Muhonen T; Pyrhönen S
Ann Oncol; 1997 Jan; 8(1):71-7. PubMed ID: 9093710
[TBL] [Abstract][Full Text] [Related]
5. Immunological response and overall survival in a subset of advanced renal cell carcinoma patients from a randomized phase 2/3 study of naptumomab estafenatox plus IFN-α versus IFN-α.
Elkord E; Burt DJ; Sundstedt A; Nordle Ö; Hedlund G; Hawkins RE
Oncotarget; 2015 Feb; 6(6):4428-39. PubMed ID: 25669986
[TBL] [Abstract][Full Text] [Related]
6. CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus.
Wang EC; Moss PA; Frodsham P; Lehner PJ; Bell JI; Borysiewicz LK
J Immunol; 1995 Nov; 155(10):5046-56. PubMed ID: 7594513
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the immunomonitoring of patients with renal cell carcinoma under therapy with IL-2/IFN-alpha-2 in combination with 5-FU.
Göhring B; Riemann D; Rebmann U; Heynemann H; Schabel J; Langner J
Urol Res; 1996; 24(5):297-303. PubMed ID: 8931295
[TBL] [Abstract][Full Text] [Related]
8. [Effects of nephrectomy and interferon administration on immunological parameters in patients with renal cell carcinoma].
Arima K; Yanagawa M; Sugimura Y; Tochigi H; Kawamura J; Saitoh K; Yamazaki Y; Mori O; Oomoto Y; Nakagawa M
Hinyokika Kiyo; 1994 Jun; 40(6):469-74. PubMed ID: 8073952
[TBL] [Abstract][Full Text] [Related]
9. T-cell subpopulation in patients with metastatic renal cell carcinoma treated by recombinant interleukin-2, recombinant interferon-alpha, 5-fluorouracil, and vinblastine.
Gez E; Mekori T; Struminger L; Rubinov R; Nativ O; Stein A; Haim N; Kuten A
Cancer Invest; 1999; 17(4):259-63. PubMed ID: 10225005
[TBL] [Abstract][Full Text] [Related]
10. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
Elsässer-Beile U; Rindsfüser M; Grussenmeyer T; Schultze-Seemann W; Wetterauer U
Br J Cancer; 2000 Sep; 83(5):637-41. PubMed ID: 10944605
[TBL] [Abstract][Full Text] [Related]
12. Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells.
Porta C; Bonomi L; Lillaz B; Paglino C; Rovati B; Imarisio I; Morbini P; Villa C; Danova M; Mensi M; Rovereto B
Anticancer Res; 2007; 27(1A):165-73. PubMed ID: 17352228
[TBL] [Abstract][Full Text] [Related]
13. Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival.
Donskov F; Bennedsgaard KM; Von Der Maase H; Marcussen N; Fisker R; Jensen JJ; Naredi P; Hokland M
Br J Cancer; 2002 Jul; 87(2):194-201. PubMed ID: 12107842
[TBL] [Abstract][Full Text] [Related]
14. [Immunological study of the postoperative adjuvant treatment with interferon gamma in patients with renal cell cancer--measurement of peripheral blood lymphocyte subsets with three color flow cytometry].
Yasunaga Y; Nishimura K; Miura H; Takatera H; Kuroda H; Kishimoto T; Fujioka H
Hinyokika Kiyo; 1995 Feb; 41(2):85-92. PubMed ID: 7702012
[TBL] [Abstract][Full Text] [Related]
15. [A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes].
Kawata N; Ono M; Kodama M; Yamanaka Y; Hirakata H; Hirano D; Fuse T; Takimoto Y
Hinyokika Kiyo; 1995 Jan; 41(1):21-6. PubMed ID: 7900565
[TBL] [Abstract][Full Text] [Related]
16. Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma.
Li Y; Guo Z; Liu CF; Xing WG; Si TG; Liu F; Guo XY; Xing JZ
Cryobiology; 2012 Aug; 65(1):56-9. PubMed ID: 22521783
[TBL] [Abstract][Full Text] [Related]
17. [Changes of lymphocyte subsets in peripheral blood of patients with hepatitis C].
Wan H; Li Y; Yang N; Yuan W; Xie N; Wang D; Guo T; Mao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1058-61. PubMed ID: 25270208
[TBL] [Abstract][Full Text] [Related]
18. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
19. Relation of prenephrectomy CD profiles and serum cytokines to the disease outcome and response to IFN-alpha/IL-2 therapy in renal cell carcinoma patients.
Lauerová L; Dusek L; Spurny V; Simicková M; Rovny A; Rejthar A; Kocák I; Kovarík J
Oncol Rep; 2001; 8(3):685-92. PubMed ID: 11295103
[TBL] [Abstract][Full Text] [Related]
20. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]